Profound Medical Corp. (PROF) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 237.93M |
| Enterprise Value | 162.59M |
| P/E Ratio | -6.05 |
| PEG Ratio | -0.15 |
| Price/Sales Ratio | 11.24 |
| Price/Book Ratio | 4.29 |
| Enterprise/Revenue | 9.62 |
| Enterprise/EBITDA | -5.46 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | -1.71 |
| Operating Margin | -1.84 |
AD
Management Effectiveness
| Return On Assets | -0.52 |
| Return On Equity | -0.62 |
Income Statement
| Revenue | 16.38M |
| Revenue/Share | 0.52 |
| Gross Profit | 11.59M |
| EBITDA | -41.41M |
| Net Income | -43.32M |
| Diluted EPS | -1.43 |
Balance Sheet
| Total Cash | 38.27M |
| Total Cash/Share | 1.05 |
| Total Debt | 7.26M |
| Total Debt/Equity | 0.15 |
| Current Ratio | 6.46 |
| Book Value Per Share | 1.37 |
Price History
| 52-Week Change | 2.82 |
| 52-Week High | 8.95 |
| 52-Week Low | 4.8 |
| Moving Average 50 Days | 6.67 |
| Moving Average 200 Days | 6.84 |
Statistics
| Average Volume | 121,279 |
| Shares Outstanding | 36.34M |
| % Held by Institutions | 44.19 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:10 |
| Last Split Date | October 16, 2019 |
AD
